Clinical Trials Logo

Intestinal Barrier Function clinical trials

View clinical trials related to Intestinal Barrier Function.

Filter by:
  • None
  • Page 1

NCT ID: NCT03744221 Completed - Clinical trials for Protein Digestion Kinetics

Health Effects of Sustainable Future Proteins

Su-Pro
Start date: November 5, 2018
Phase: N/A
Study type: Interventional

In the current study the investigators aim to assess the nutritional quality and bio-functional activity of two alternative protein sources bovine plasma and corn and from the benchmark protein whey. The study is a double blind, randomised, cross-over, short-term trial in which 36 healthy study subjects will receive three protein interventions of 1 week with a washout period of 1 week between interventions. Study subjects will visit the research facility before and after the intervention period on two separate occasions to measure gut permeability via a multi-sugar test and to collect fasting blood samples and blood pressure outcomes. Faecal and saliva samples before and after each intervention will be collected. A subgroup of 12 study participants will also be subjected to a postprandial digestibility test on the first day of the interventions. The main study parameter is to assess the protein digestion kinetics and protection of the epithelial barrier. Secondary study parameters include other markers of gastrointestinal health, metabolic health, vascular health and satiating properties.

NCT ID: NCT03611400 Completed - Clinical trials for Intestinal Barrier Function

The Effect of Probiotic Intake on Intestinal Permeability in Healthy Adults

PIP
Start date: August 22, 2018
Phase: N/A
Study type: Interventional

In this double blind, crossover study participants will take a placebo for 3 weeks each. Gut permeability will be assessed weekly using food-grade sugar molecules. On the second week, participants will take aspirin, which will make their intestine permeable to the sugars. Participants will be asked to provide urine and stool samples to assess gut permeability and microbial communities. No change in permeability to the small sugar probes is anticipated with the probiotic.

NCT ID: NCT01686204 Completed - Clinical trials for Chronic Inflammation

Reduction of Obesity-Associated Intestinal Inflammation by Low-Fat Dairy Yogurt

Start date: September 2012
Phase: N/A
Study type: Interventional

The main objective of this work is to conduct a clinical trial in obese and non-obese individuals testing the ability of low-fat dairy yogurt to improve gastrointestinal health and reduce chronic inflammation. Our central hypothesis is that short and long-term consumption of low-fat dairy yogurt will reduce inflammation to a greater extent in obese individuals by improving intestinal barrier function.